News
The regulatory actions were based on results from the Phase III MATTERHORN trial (NCT04592913), which showed that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback